307 related articles for article (PubMed ID: 21489361)
1. Correlation between Dermatology Life Quality Index and Minor test and differences in their levels over time in patients with axillary hyperhidrosis treated with botulinum toxin type A.
Skroza N; Bernardini N; La Torre G; La Viola G; Potenza C
Acta Dermatovenerol Croat; 2011; 19(1):16-20. PubMed ID: 21489361
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
Rosell K; Hymnelius K; Swartling C
Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
[TBL] [Abstract][Full Text] [Related]
4. Thirty-five units of botulinum toxin type A for treatment of axillary hyperhidrosis in female patients.
Marcella S; Goodman G; Cumming S; Foley P; Morgan V
Australas J Dermatol; 2011 May; 52(2):123-6. PubMed ID: 21605096
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
Heckmann M; Ceballos-Baumann AO; Plewig G;
N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
[TBL] [Abstract][Full Text] [Related]
6. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
Solish N; Benohanian A; Kowalski JW;
Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
8. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
[TBL] [Abstract][Full Text] [Related]
9. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series.
Kouris A; Armyra K; Stefanaki C; Christodoulou C; Karimali P; Kontochristopoulos G
Pediatr Dermatol; 2015; 32(2):226-30. PubMed ID: 25557249
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
[TBL] [Abstract][Full Text] [Related]
12. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
[TBL] [Abstract][Full Text] [Related]
13. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
Doft MA; Kasten JL; Ascherman JA
Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
[TBL] [Abstract][Full Text] [Related]
14. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
[TBL] [Abstract][Full Text] [Related]
15. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
[TBL] [Abstract][Full Text] [Related]
16. Bilateral thoracoscopic T2 to T3 sympathectomy versus botulinum injection in palmar hyperhidrosis.
Ambrogi V; Campione E; Mineo D; Paternò EJ; Pompeo E; Mineo TC
Ann Thorac Surg; 2009 Jul; 88(1):238-45. PubMed ID: 19559233
[TBL] [Abstract][Full Text] [Related]
17. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of botulinum toxin A in the treatment of axillary and palmar hyperhidrosis: 10 cases].
Maillard H; Briand N; Bara C; Celerier P
Ann Dermatol Venereol; 2003 May; 130(5):511-3. PubMed ID: 12843826
[TBL] [Abstract][Full Text] [Related]
19. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
Vadoud-Seyedi J; Simonart T
Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
[TBL] [Abstract][Full Text] [Related]
20. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients.
Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM
J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
